Biopharma | search
Click here to view Biopharma news from 60+ newspapers.
Bookmark or Share- Biotech and Pharma Industry News | BioPharma DiveBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
- 5 FDA decisions to watch in the second quarter - BioPharma DiveBioPharma The FDA could soon expand use of two multiple myeloma cell therapies as well as a top-selling medicine from Sanofi and Regeneron, while Pfizer’s years of gene therapy work might finally pay dividends.
- Zenas, with new funding, aims dual-targeting antibody ... - BioPharma DiveBiotechnology startup Zenas BioPharma on Tuesday said it has raised $200 million to support testing of a dual-targeting antibody drug it’s developing for inflammatory diseases. The Series C round will finance trials of a drug called obexelimab that Zenas acquired from antibody maker Xencor two-and-a-half years ago. A late-stage test is ...
- Deep Dive - BioPharma DiveBioPharma Dive’s Delilah Alvarado worked with reporters from Healthcare Dive to examine the impact of state laws banning abortion on people trying to conceive via in vitro fertilization. Sydney Halleman, Delilah Alvarado, Shaun Lucas and Jasmine Ye Han • Oct. 24, 2022
- The biopharma industry outlook on 2024: Guarded optimism for a reboundBrian Tucker / BioPharma Dive Guarded optimism seems to be the mood of the biopharmaceutical industry to start 2024. Last year brought a stock market slide and layoffs for more than 150 drug companies.
More
